At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 40 enrolled
Drug / intervention
Transcranial direct current stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's: a Randomized, Sham-controlled Clinical Trial
In Brief
A Phase 2 clinical trial evaluating Transcranial direct current stimulation for Apathy and Alzheimer's Disease. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This is a phase 2 double-blind, randomized, sham-controlled study to investigate the effects of repeated transcranial direct current stimulation for the treatment of apathy in moderate Alzheimer's Disease in patients selected from an outpatient clinics in São Paulo, Brazil.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsApathy, Alzheimer's Disease
CountriesBrazil
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 2011
Enrollment StartJan 2012
Primary CompletionMay 2012
TodayJul 2026
First PostedNov 29, 2011
Enrollment StartJan 1, 2012
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.6 years ago
Interventions
Transcranial direct current stimulationdevice
tDCS 2 mA, dorsolateral pre-frontal cortex